e-ISSN: 2717-7149
  • Home
  • About The Journal
  • Editorial Board
  • Instructions for Authors
  • Contact
Current Issue
Ahead Of Print
Archive
Search
Most Popular
Download Articles Read Articles
Retina Arter Tıkanıklıkları ve Tedavisi...
Santral Retinal Ven Tıkanıklığı Güncel Tedavisi...
Central Retinal Artery Occlusion As the Cause of Unilateral Concentric Narrowing of Visual Field and Presence of Cilioretinal Artery...
Bilateral Optic Disc Drusen
Vascular Endothelial Growth Factor and Anti VEGF Agents...
Central Retinal Artery Occlusion As the Cause of Unilateral Concentric Narrowing of Visual Field and Presence of Cilioretinal Artery...
Retina Arter Tıkanıklıkları ve Tedavisi...
Morning Glory Syndrome Associated with Retinochoroidal Coloboma...
Santral Retinal Ven Tıkanıklığı Güncel Tedavisi...
Bilateral Optic Disc Drusen
PureSee Kesintisiz Yüksek Kalitede Görüş
Retina-Vitreous 2011 , Vol 19 , Num 1
Turkish Abstract Abstract Article PDF Similar Articles Mail to Author
Macular Grid Laser Photocoagulation Treatment Versus Intravitreal Bevacizumab Injections for Macular Edema Secondary to Branch Retinal Vein Occlusion
Damla ERGİNTÜRK ACAR1, Nurten ÜNLÜ2, Dicle HAZIROLAN3, Esra KARABULUT1, Güner ÜNEY4, Mehmet Akif ACAR5
1S. B. Ankara Eğitim ve Araştırma Hast., 1.Göz Kliniği, Ankara, Asist. Dr.
2S. B. Ankara Eğitim ve Araştırma Hast., 1.Göz Kliniği, Ankara, Doç. Dr.
3S. B. Ankara Eğitim ve Araştırma Hast., 1.Göz Kliniği, Ankara, Uzm. Dr.
4S. B. Ankara Eğitim ve Araştırma Hast., 2.Göz Kliniği, Ankara, Uz. Dr.
5S. B. Ankara Eğitim ve Araştırma Hast., 2.Göz Kliniği, Ankara, Doç. Dr.
Purpose: To compare the outcomes of grid laser photocoagulation and intravitreal (IV) injections of bevacizumab treatments in patients with macular edema secondary to branch retinal vein occlusion (BRVO).
Materials and Methods: Records of 15 patients treated with grid laser photocoagulation (group 1) and 12 patients treated with IV bevacizumab injections (group 2) for macular edema secondary to BRVO reviewed retrospectively. Best corrected visual acuity (BCVA) and central macular thickness (CMT) obtained by Stratus OCT were measured.
Results: Mean follow-up time was 9.9±3.1 months in group 1 and 13.2±7.6 months in group 2. BCVA improved significantly from 0.73±0.28 logMAR to 0.55±0.36 logMAR in grid laser photocoagulation group and 0.94±0.43 logMAR to 0.55±0.44 logMAR in IV injection group (respectively p=0.010 and p=0.011). CMT was decreased from 391.6±119.1 μm to 336.4±128.7 μm in group 1 and from 555.7±130.3 μm to 354.2±144.0 μm in group 2. In between group comparisons there were no difference in initial BCVA and BCVA change (respectively p=0.136 and p=0.155). But both initial CMT measurements and CMT improvements were statistically different (respectively p=0.003 and p=0.027). No significant correlation was found between BCVA change and CMT change in both groups.
Conclusion: IV bevacizumab injection and grid laser treatment result in significant improvement of visual acuity for patients with macular edema secondary to BRVO.
Keywords : Branch retinal vein occlusion, macular edema, laser photocoagulation, bevacizumab
PureSee Kesintisiz Yüksek Kalitede Görüş
Home
About The Journal
Editorial Board
Instructions for Authors
Contact